119 related articles for article (PubMed ID: 6385972)
1. The expression of glycoproteins on single blood platelets from healthy individuals and from patients with congenital bleeding disorders.
Johnston GI; Heptinstall S; Robins RA; Price MR
Biochem Biophys Res Commun; 1984 Sep; 123(3):1091-8. PubMed ID: 6385972
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of platelet membrane glycoproteins in Glanzmann's thrombasthenia and the Bernard-Soulier syndrome by electroimmunoassay.
Kristopeit SM; Kunicki TJ
Thromb Res; 1984 Oct; 36(2):133-42. PubMed ID: 6506033
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric analysis of platelet surface glycoproteins: phenotypically distinct subpopulations of platelets in children with chronic myeloid leukemia.
Michelson AD
J Lab Clin Med; 1987 Sep; 110(3):346-54. PubMed ID: 3475397
[TBL] [Abstract][Full Text] [Related]
4. Analysis of human platelet glycoproteins IIb-IIIa and Glanzmann's thrombasthenia in whole blood by flow cytometry.
Jennings LK; Ashmun RA; Wang WC; Dockter ME
Blood; 1986 Jul; 68(1):173-9. PubMed ID: 3719095
[TBL] [Abstract][Full Text] [Related]
5. Immunochemical evidence for protein abnormalities in platelets from patients with Glanzmann's thrombasthenia and Bernard-Soulier syndrome.
Hagen I; Nurden A; Bjerrum OJ; Solum NO; Caen J
J Clin Invest; 1980 Mar; 65(3):722-31. PubMed ID: 7354135
[TBL] [Abstract][Full Text] [Related]
6. Monocytes and platelets share the glycoproteins IIb and IIIa that are absent from both cells in Glanzmann's thrombasthenia type I.
Gogstad G; Hetland O; Solum NO; Prydz H
Biochem J; 1983 Aug; 214(2):331-7. PubMed ID: 6225428
[TBL] [Abstract][Full Text] [Related]
7. Isolation and quantitation of the platelet membrane glycoprotein deficient in thrombasthenia using a monoclonal hybridoma antibody.
McEver RP; Baenziger NL; Majerus PW
J Clin Invest; 1980 Dec; 66(6):1311-8. PubMed ID: 6449521
[TBL] [Abstract][Full Text] [Related]
8. Glycoproteins of platelet membranes from Glanzmann's thrombasthenia. A comparison with normal using carbohydrate-specific or protein-specific labelling techniques and high-resolution two-dimensional gel electrophoresis.
McGregor JL; Clemetson KJ; James E; Capitanio A; Greenland T; Lüscher EF; Dechavanne M
Eur J Biochem; 1981 May; 116(2):379-88. PubMed ID: 7195813
[TBL] [Abstract][Full Text] [Related]
9. The use of fluorescence flow cytometry in the characterization of Bernard-Soulier syndrome and Glanzmann's thrombasthenia.
Fabris F; Casonato A; Randi ML; Luzzatto G; De Silvestro G; Ongaro G; Girolami A
Haematologica; 1989; 74(1):39-44. PubMed ID: 2498181
[TBL] [Abstract][Full Text] [Related]
10. Inherited abnormalities of platelet glycoproteins.
Caen JP; Nurden AT; Kunicki TJ
Philos Trans R Soc Lond B Biol Sci; 1981 Aug; 294(1072):281-90. PubMed ID: 6117891
[TBL] [Abstract][Full Text] [Related]
11. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa.
Niewiarowski S; Kornecki E; Hershock D; Tuszynski GP; Bennett JS; Soria C; Soria J; Dunn F; Pidard D; Kieffer N
J Lab Clin Med; 1985 Dec; 106(6):651-60. PubMed ID: 2999274
[TBL] [Abstract][Full Text] [Related]
12. Analysis of platelet abnormalities in uremia with and without Glanzmann's thrombasthenia.
Nomura S; Hamamoto K; Kawakatsu T; Kido H; Yamaguchi K; Fukuroi T; Suzuki M; Yanabu M; Shouzu A; Nishikawa M
Nephron; 1994; 68(4):442-8. PubMed ID: 7870229
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of Bernard-Soulier syndrome and Glanzmann's thrombasthenia with a monoclonal assay on whole blood.
Montgomery RR; Kunicki TJ; Taves C; Pidard D; Corcoran M
J Clin Invest; 1983 Feb; 71(2):385-9. PubMed ID: 6822670
[TBL] [Abstract][Full Text] [Related]
14. [Studies on released-ADP and membrane glycoprotein in platelets of patients with Glanzmann's thrombasthenia and essential athrombia (author's transl)].
Hayashi H; Niiya K; Koya H; Nozaki H; Kitazima K; Kimura I
Rinsho Ketsueki; 1978 Oct; 19(10):1306-13. PubMed ID: 153981
[No Abstract] [Full Text] [Related]
15. Molecular abnormalities in Glanzmann's thrombasthenia, Bernard-Soulier syndrome, and platelet-type von Willebrand's disease.
Clemetson KJ; Clemetson JM
Curr Opin Hematol; 1994 Sep; 1(5):388-93. PubMed ID: 9371310
[TBL] [Abstract][Full Text] [Related]
16. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
[TBL] [Abstract][Full Text] [Related]
17. Deletion of the platelet-specific alloantigen PlA1 from platelets in Glanzmann's thrombasthenia.
Kunicki TJ; Aster RH
J Clin Invest; 1978 May; 61(5):1225-31. PubMed ID: 566280
[TBL] [Abstract][Full Text] [Related]
18. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor.
Coller BS; Peerschke EI; Seligsohn U; Scudder LE; Nurden AT; Rosa JP
J Lab Clin Med; 1986 Apr; 107(4):384-92. PubMed ID: 2420911
[TBL] [Abstract][Full Text] [Related]
19. A variant of Glanzmann's thrombasthenia characterized by abnormal glycoprotein IIb/IIIa complex formation.
Fournier DJ; Kabral A; Castaldi PA; Berndt MC
Thromb Haemost; 1989 Nov; 62(3):977-83. PubMed ID: 2512684
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of drug-dependent platelet antigens and their antibodies in quinine- and quinidine-induced thrombocytopenia: involvement of glycoproteins Ib, IIb, IIIa, and IX.
Pfueller SL; Bilston RA; Logan D; Gibson JM; Firkin BG
Blood; 1988 Oct; 72(4):1155-62. PubMed ID: 2971407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
